The Global HIV Vaccine Enterprise
is an alliance of independent organizations around the world dedicated to accelerating the development of a preventive HIV vaccine by:
- Shared scientific plan: Implementing a strategic plan for HIV vaccine research that spans vaccine discovery, product development and manufacturing, and clinical trials
- Increased resources: Mobilizing significant new funding to achieve the scientific plan
- Greater collaboration: Promoting more efficient, faster ways for researchers to share successes and failures and avoid duplication of efforts
The Enterprise Approach
Message from Alan Bernstein
As he concludes his first few months as Executive Director of the Enterprise, Dr. Bernstein would like to update everyone on Enterprise activities, reflect upon recent developments in the field, and identify some initial priorities for the organization over the coming year. Click the link below for his update.
Message from Alan Bernstein
Canadian HIV Vaccine Initiative—Funding Opportunity
An "Invitation to Submit Applications" for a pilot scale HIV vaccine manufacturing facility in Canada for clinical trial lots was released. The Canadian HIV Vaccine Initiative (CHVI) is a collaboration between the Government of Canada and the Bill & Melinda Gates Foundation with the overall goal to coordinate Canadian and international efforts to support the Global HIV Vaccine Enterprise.
Visit the CHVI website http://www.chvi-icvv.gc.ca/new-eng.html for guidelines and forms related to this funding opportunity.
Scientific Strategic Plan
The Enterprise's scientific strategic plan for accelerating HIV vaccine research was published in the February 2005 issue of Public Library of Science (PLoS) — Medicine